Betterlife Pharma Inc. (TSE:BETR) has released an update.
BetterLife Pharma Inc., a biotech company specializing in non-hallucinogenic LSD-based treatments for mental disorders, has announced plans for a Non-Brokered Private Placement aiming to raise $500,000. These funds are intended to advance the development of their leading drug candidate, BETR-001, and for general corporate purposes. The offering will include common shares and warrants, with the closing date to be announced following completion.
For further insights into TSE:BETR stock, check out TipRanks’ Stock Analysis page.
